Sign in
Taking people in United StatesPhase 4

Malabsorption Blood Test (MBT) to Determine Exocrine Pancreatic Function and Related Quality of Life in Chronic Pancreatitis

Key facts

Who runs it
Anna Evans Phillips
Where
Baltimore and Pittsburgh, United StatesSee the 2 sites
Trial code
Status
Recruiting
Phase
Phase 4
People taking part
80 people, planned
Started
20 Apr 2026
Expected to end
Sept 2028
Type of study
Interventional, 6 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Pancreatic Enzyme Replacement Therapy
  • Placebo
  • MBT1
  • MBT 2
Record updated
11 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • ≥ 18 years of age
  • RAP (≥ 2 documented lifetime attacks with ≥ 2 of 3 acute pancreatitis criteria) OR Chronic pancreatitis (Cambridge I or II with documented history of AP OR Cambridge III or IV criteria)
  • Fecal elastase ≥ 50 within the preceding 12 months

Who cannot take part

  • Taking medications that alter fat absorption or that supplement the fatty acids being studied (e.g. orlistat, ursodeoxycholic acid, Fatty-15 fatty acid supplement etc.)
  • Taking GLP-1 Receptor Agonist therapy
  • Receiving Pancreatic Enzyme Replacement Therapy for > 5 days within the preceding 30 days
  • Allergy/Intolerance to PERT/MBT
  • Fecal elastase <50 within preceding 12 months OR pre-existing diagnosis of severe Exocrine Pancreatic Insufficiency, or ongoing steatorrhea
  • History of pancreatic resection or underlying malabsorptive disease
  • Other significant medical condition as judged by Principal Investigator
  • Acute Pancreatitis attack (documented and meeting at least 2 of 3 criteria) within the preceding 90 days
  • Pregnant or Breast Feeding

This trial is currently available in United States.

  • Johns Hopkins MedicineBaltimore, United StatesContact: Yeganeh Pasebani, MDNot yet recruiting
  • University of Pittsburgh Medical CenterPittsburgh, United StatesContact: Anna E Phillips, MD MSTaking people

About the trial

What the trial wants to find out

This project uses the Malabsorption Blood Test (MBT) to identify patients with recurrent acute or chronic pancreatitis who have mild to moderate exocrine pancreatic insufficiency. A subgroup of patients who have response to pancreatic enzyme replacement therapy will enter a randomized, placebo-controlled pilot clinical trial for 8 weeks to identify improvements in quality of life (QOL).

The 6 groups in the trial

  • MBT1-MBT2Existing treatment, for comparison

    Participants will undergo the MBT off PERT followed by the MBT on PERT. They will not be enrolled in the randomized trial.

    Treatment: MBT1 and MBT 2

  • MBT2-MBT1Existing treatment, for comparison

    Participants will undergo MBT on PERT followed by MBT off PERT. Participants will not be enrolled in the randomized clinical trial.

    Treatment: MBT1 and MBT 2

  • MBT1-MBT2 Pancreatic EnzymeExisting treatment, for comparison

    Participants will undergo MBT off PERT followed by MBT on PERT, and subsequently be randomized to the clinical trial arm treated with PERT.

    Treatment: Pancreatic Enzyme Replacement Therapy, MBT1, and MBT 2

  • MBT1-MBT2 PlaceboExisting treatment, for comparison

    Participants will undergo MBT off PERT followed by MBT on PERT, and subsequently be randomized to the clinical trial arm treated with placebo.

    Treatment: Placebo, MBT1, and MBT 2

  • MBT2-MBT1 PERTExisting treatment, for comparison

    Participants will undergo MBT on PERT followed by MBT off PERT, and subsequently be randomized to the clinical trial arm treated with PERT.

    Treatment: Pancreatic Enzyme Replacement Therapy, MBT1, and MBT 2

  • MBT2-MBT1 PlaceboExisting treatment, for comparison

    Participants will undergo MBT on PERT followed by MBT off PERT, and subsequently be randomized to the clinical trial arm treated with placebo.

    Treatment: Placebo, MBT1, and MBT 2

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
11 September 2026